mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

Shernan G. Holtan, Luis F. Porrata, Joseph P. Colgan, Clive S. Zent, Thomas M. Habermann, Svetomir N. Markovic

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)688-689
Number of pages2
JournalAmerican journal of hematology
Issue number8
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Hematology

Cite this